High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program-Reference-Cited by-同舟云学术

High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program

Published:2021-04-07 Issue:16 Volume:127 Page:3019-3028
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Park Sehhoon¹,Olsen Steve²,Ku Bo Mi¹^ORCID,Lee Min‐Sang¹^ORCID,Jung Hyun‐Ae¹^ORCID,Sun Jong‐Mu¹,Lee Se‐Hoon¹,Ahn Jin Seok¹,Park Keunchil¹^ORCID,Choi Yoon‐La³,Ahn Myung‐Ju¹^ORCID

Affiliation:

1. Division of Hematology‐Oncology Department of Medicine Samsung Medical CenterSungkyunkwan University School of Medicine Seoul Republic of Korea

2. Department of Medical and Clinical Affairs Guardant Health AMEA Singapore Singapore

3. Department of Pathology and Translational Genomics Samsung Medical CenterSungkyunkwan University School of Medicine Seoul Republic of Korea

Funder

Österreichische Nationalstiftung für Forschung, Technologie und Entwicklung

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33571

Reference25 articles.

1. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

2. First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

3. Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

4. STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

5. Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Validity and Utility of Circulating Tumor DNA (ctDNA) Testing in Advanced Non-small Cell Lung Cancer (aNSCLC): A Systematic Literature Review and Meta-analysis;Molecular Diagnosis & Therapy;2024-08-02

2. NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in China;Lung Cancer;2024-08

3. Point of Care Liquid Biopsy for Cancer Treatment—Early Experience from a Community Center;Cancers;2024-07-10

4. Liquid profiling for patients with advanced cancer is ready for clinical integration;memo - Magazine of European Medical Oncology;2024-05-16

5. Circulating tumor DNA- and cancer tissue-based next-generation sequencing reveals comparable consistency in targeted gene mutations for advanced or metastatic non-small cell lung cancer;Chinese Medical Journal;2024-05-06